Growth Hormone-Releasing Peptides (GHRPs) can be influenced by blood glucose, free fatty acids, glucocorticoids and somatostatin
"This approval for Ozempic allows us to more broadly address conditions within cardiovascular-kidney-metabolic syndrome, which affects millions of adults and could have serious consequences if left untreated," remarked Anna Windle, head of clinical development, medical, and regulatory affairs at Novo Nordisk
Written by Benton Lowey-Ball, BS Behavioral Neuroscience References: McCracken, E., Monaghan, M., & Sreenivasan, S
Mitochondrial Dysfunction as a Force Multiplier Mitochondria act as both generators and sensors of oxidative stress, amplifying redox imbalance and accelerating cellular dysfunction across metabolically active tissues